Metrasens

Metrasens specializes in advanced detection technologies focused on security screening solutions that efficiently identify ferrous threats in various environments, enhancing safety and security protocols for diverse institutions. Metrasens, established in 2005, operates from Malvern, UK, and is dedicated to providing innovative security screening solutions. The company received GBP 3. 00 million in funding in March 2013 from C5 Capital and Octopus Investments.

Simon Goodyear, the founder and current CEO, has been instrumental in steering the company's growth and technological advancements. Metrasens has successfully raised a total of GBP 3. 00 million and currently holds a valuation of GBP 13. 46 million.

Metrasens specializes in advanced detection technologies, primarily focusing on security screening solutions that identify ferrous threats, such as weapons, in various environments. Its flagship product, Metrasens Ultra, provides unobtrusive screening experiences, ensuring thorough checks without compromising user comfort. The company caters to educational institutions, healthcare facilities, correctional facilities, and corporate environments, enhancing safety during events and daily operations. Metrasens products are deployed globally, significantly in the United States, serving over 149 hospitals and 698 correctional facilities, addressing safety and security needs in high-traffic areas.

Metrasens reported a revenue of GBP 23,036,920. 30 for the year 2024, with a negative EBITDA of GBP 3,046,325. The company generates revenue through direct sales of its screening products and services, primarily to institutions seeking to enhance their security measures. Their pricing structure includes upfront costs for equipment and optional ongoing maintenance agreements.

Metrasens plans to leverage its recent funding of GBP 3. 00 million from March 2013 to expand its product offerings and enhance its market presence. The company aims to introduce new products designed for security screening, targeting release within the next fiscal year. Additionally, Metrasens is exploring opportunities to enter new markets in Asia and Europe by 2025, aiming to broaden its geographical reach and support its growth strategy.